- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/515 - Angiogenic factorAngiogenin
Patent holdings for IPC class C07K 14/515
Total number of patents in this class: 246
10-year publication summary
|
27
|
22
|
24
|
15
|
20
|
14
|
12
|
13
|
10
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10829 |
17 |
| Modernatx, Inc. | 1262 |
16 |
| Regeneron Pharmaceuticals, Inc. | 4261 |
9 |
| NAIDU, L.P., Satyanarayan Naidu, a United States citizen, and Smita Naidu, a United States citizen | 36 |
7 |
| The Regents of the University of California | 19943 |
6 |
| Retinal Solutions LLC | 16 |
6 |
| Vasomune Therapeutics Inc. | 7 |
6 |
| Agriculture Victoria Services Pty Ltd | 172 |
4 |
| Askgene Pharma, Inc. | 49 |
4 |
| Murray Goulburn Co-operative Co. Limited | 20 |
4 |
| Ottawa Hospital Research Institute | 109 |
4 |
| Sunnybrook Research Institute | 238 |
4 |
| Verve Therapeutics, Inc. | 37 |
4 |
| Samsung Electronics Co., Ltd. | 146534 |
3 |
| Amgen Inc. | 4049 |
3 |
| Northwestern University | 3400 |
3 |
| California Northstate College of Pharmacy, LLC | 20 |
3 |
| Children's Medical Center Corporation | 1863 |
3 |
| Chugh, Sumant S. | 4 |
3 |
| Pieris Pharmaceuticals GmbH | 100 |
3 |
| Other owners | 134 |